Developing rapid instrument-free diagnostic technologies to reduce the need for multiple lab-based tests.


Currently, a cancer diagnosis is an iterative, multi-step process requiring analysis of a tissue biopsy by a pathologist, followed by several lab-based tests (molecular and genetic). These lab-based tests account for 90% of the time and cost associated with diagnosis and contribute to 44% of pathology delays.


Panakeia’s software can provide pathologists with all the information needed for diagnosis and treatment from initial biopsies – eliminating the need for lab tests.


Website and social media

UN Sustainable Development Goals

Contact us

    I'd like to contact this venture...